<?xml version="1.0" encoding="UTF-8"?>
<p>Another antiviral drug, nelfinavir, an HIV protease inhibitor, was predicted to be a potential inhibitor of COVID-19 [
 <xref rid="B26" ref-type="bibr">26</xref>]. In addition, cytokine immunotherapy with IFN-α, a broad spectrum antiviral drug, has been used to inhibit HBV. IFN-α was used to treat patients infected with SARS-CoV-2 according to established guidelines [
 <xref rid="B70" ref-type="bibr">70</xref>]. IFN-α combined with LPV/r was shown to be beneficial for treatment of COVID-19 [
 <xref rid="B78" ref-type="bibr">78</xref>].
</p>
